SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GPT Healthcare gets SEBI's nod to raise Rs 500 crore via IPO

04 Jan 2022 Evaluate

GPT Healthcare has received market regulator -- Securities Exchange Board of India’s (SEBI's) approval for its Rs 500 crore initial public offer (IPO). The company, which filed the draft red herring prospectus with the SEBI in August, got the regulator’s approval on December 29, 2021.

Proceeds from the fresh issuance of shares will be used to purchase medical equipment and for general corporate purposes. DAM Capital and SBI Capital Markets are the lead managers to the issue.

GPT Healthcare operates a chain of mid-sized hospitals in eastern India under the 'ILS Hospitals' brand and provides integrated healthcare services, with a focus on secondary and tertiary care.

GPT Healthcare Share Price

135.95 0.70 (0.52%)
16-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×